Processa Pharmaceuticals Inc (PCSA)
1.06
-0.01
(-0.93%)
USD |
NASDAQ |
Nov 14, 16:00
1.06
0.00 (0.00%)
After-Hours: 18:04
Processa Pharmaceuticals Total Liabilities (Quarterly): 1.577M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.577M |
March 31, 2024 | 1.061M |
December 31, 2023 | 0.7975M |
September 30, 2023 | 0.9148M |
June 30, 2023 | 0.9307M |
March 31, 2023 | 2.290M |
December 31, 2022 | 1.149M |
September 30, 2022 | 1.364M |
June 30, 2022 | 1.576M |
March 31, 2022 | 1.064M |
December 31, 2021 | 0.9784M |
September 30, 2021 | 1.817M |
June 30, 2021 | 1.896M |
March 31, 2021 | 2.002M |
December 31, 2020 | 2.275M |
September 30, 2020 | 4.062M |
June 30, 2020 | 3.418M |
March 31, 2020 | 2.778M |
December 31, 2019 | 2.871M |
September 30, 2019 | 2.151M |
June 30, 2019 | 2.804M |
March 31, 2019 | 2.954M |
December 31, 2018 | 2.780M |
September 30, 2018 | 2.957M |
Date | Value |
---|---|
June 30, 2018 | 3.131M |
March 31, 2018 | 5.610M |
December 31, 2017 | 2.610M |
September 30, 2017 | 0.1153M |
June 30, 2017 | 2.493M |
March 31, 2017 | 2.439M |
December 31, 2016 | 2.354M |
September 30, 2016 | 2.285M |
June 30, 2016 | 2.214M |
March 31, 2016 | 2.165M |
December 31, 2015 | 2.083M |
September 30, 2015 | 2.116M |
June 30, 2015 | 2.198M |
March 31, 2015 | 1.841M |
December 31, 2014 | 1.338M |
September 30, 2014 | 2.783M |
June 30, 2014 | 2.162M |
March 31, 2014 | 1.878M |
December 31, 2013 | 1.267M |
September 30, 2013 | 1.466M |
June 30, 2013 | 2.457M |
March 31, 2013 | 1.449M |
December 31, 2012 | 1.322M |
September 30, 2012 | 1.296M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7975M
Minimum
Dec 2023
4.062M
Maximum
Sep 2020
1.833M
Average
1.577M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 4.542M |
Palatin Technologies Inc | 10.85M |
iBio Inc | 7.41M |
Theriva Biologics Inc | 14.74M |
Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.601M |
Shareholders Equity (Quarterly) | 6.024M |